ESLA

Estrella Immunopharma Inc.

NASDAQ: ESLA · HEALTHCARE · BIOTECHNOLOGY

$0.41

-8.66% today

Updated 2026-11-05

Market cap

$18.54M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.17

Dividend yield

—

52W range

$0 – $3

Volume

2.3M

Market cap

$18.54M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.17

Dividend yield

—

52W range

$0 – $3

Volume

2.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

2.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-34.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$12.00

+2862.23%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -34.35 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.78M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	—	$0.00	$0.00
Net income	$-11.11M	$-7.31M	$-8.85M	$-13.06M	$-2.31M
EPS	—	—	—	—	$-0.17
Free cash flow	$-1.04M	$-16.07M	$-3.11M	$-1.79M	$-1.78M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ESLA	$18.54M	18	4.3	3.0	5.0	2.8	—	Avoid
LLY	$1.26T	74	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$657.68B	54	4.7	8.5	2.7	5.5	-89.35%	Buy
ABBV	$521.11B	77	6.7	9.0	4.0	5.0	-88.02%	Strong Buy
MRK	$368.89B	44	3.3	6.5	2.0	5.0	-76.61%	Hold
UNH	$365.29B	62	6.7	6.0	4.7	5.5	-24.78%	Buy

Smart narrative

Estrella Immunopharma Inc. trades at $0.41. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -34.35, it sits in the distress.

Frequently asked questions

What is Estrella Immunopharma Inc.'s stock price?

Estrella Immunopharma Inc. (ESLA) trades at $0.41.

Is Estrella Immunopharma Inc. overvalued?

Estrella Immunopharma Inc. carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Estrella Immunopharma Inc. (ESLA)?

The 12-month analyst consensus target is $12.00, about 2862.2% above the current $0.41. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Estrella Immunopharma Inc.'s Altman Z-Score is -34.35, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-268.50%

Beta0.89

50D MA$0.58

200D MA$0.99

Shares out0.04B

Float0.04B

Short ratio—

Avg volume2.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ESLA vs LLY →ESLA vs JNJ →ESLA vs ABBV →Stock screener →